GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » Cyclically Adjusted PB Ratio

Eusol Biotech Co (ROCO:6652) Cyclically Adjusted PB Ratio : 1.64 (As of May. 04, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co Cyclically Adjusted PB Ratio?

As of today (2025-05-04), Eusol Biotech Co's current share price is NT$6.00. Eusol Biotech Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 was NT$3.66. Eusol Biotech Co's Cyclically Adjusted PB Ratio for today is 1.64.

The historical rank and industry rank for Eusol Biotech Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

ROCO:6652' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.64
Current: 1.64

During the past 10 years, Eusol Biotech Co's highest Cyclically Adjusted PB Ratio was 1.64. The lowest was 0.00. And the median was 0.00.

ROCO:6652's Cyclically Adjusted PB Ratio is ranked worse than
52.25% of 668 companies
in the Biotechnology industry
Industry Median: 1.48 vs ROCO:6652: 1.64

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eusol Biotech Co's adjusted book value per share data of for the fiscal year that ended in Dec24 was NT$2.668. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$3.66 for the trailing ten years ended in Dec24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eusol Biotech Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Eusol Biotech Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co Cyclically Adjusted PB Ratio Chart

Eusol Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.19

Eusol Biotech Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 2.19

Competitive Comparison of Eusol Biotech Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Eusol Biotech Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eusol Biotech Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eusol Biotech Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eusol Biotech Co's Cyclically Adjusted PB Ratio falls into.


;
;

Eusol Biotech Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Eusol Biotech Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6.00/3.66
=1.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eusol Biotech Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec24 is calculated as:

For example, Eusol Biotech Co's adjusted Book Value per Share data for the fiscal year that ended in Dec24 was:

Adj_Book=Book Value per Share/CPI of Dec24 (Change)*Current CPI (Dec24)
=2.668/133.1571*133.1571
=2.668

Current CPI (Dec24) = 133.1571.

Eusol Biotech Co Annual Data

Book Value per Share CPI Adj_Book
201512 2.303 99.792 3.073
201612 3.398 101.863 4.442
201712 4.361 104.011 5.583
201812 3.855 105.998 4.843
201912 2.927 108.420 3.595
202012 2.086 109.897 2.528
202112 3.168 117.630 3.586
202212 3.079 125.222 3.274
202312 2.927 129.419 3.012
202412 2.668 133.157 2.668

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eusol Biotech Co  (ROCO:6652) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Eusol Biotech Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eusol Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No.135, Section 3, Minsheng East Road, 6th Floor, Songshan District, Taipei, TWN, 10546
Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co Headlines

No Headlines